bone

BienRaz Launches Premium D3 + K2 Formula for Bone Health and Heart Function

NEW YORK, April 04, 2026 (GLOBE NEWSWIRE) -- As research continues to reveal the critical relationship between vitamin D3 and…

7 days ago

Accord Healthcare Announces Launch of Denosumab – Second Biosimilar in Bone Health

∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information.LONDON, Dec. 2, 2025 /PRNewswire/…

4 months ago

Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment

Abbott's denosumab biosimilar is the first approved in Thailand, making advanced therapy for osteoporosis and cancer-related bone loss more affordable for…

8 months ago